Ivabradine acutely improves cardiac Ca handling and function in a rat model of Duchenne muscular dystrophy
Abstract The muscular dystrophies caused by dystrophin deficiency, the so‐called dystrophinopathies, are associated with impaired cardiac contractility and arrhythmias, which considerably contribute to disease morbidity and mortality. Impaired Ca handling in ventricular cardiomyocytes has been ident...
Main Authors: | Petra Lujza Szabo, Jessica Marksteiner, Janine Ebner, Christopher Dostal, Bruno K. Podesser, Jakob Sauer, Helmut Kubista, Hannes Todt, Benjamin Hackl, Xaver Koenig, Attila Kiss, Karlheinz Hilber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Physiological Reports |
Subjects: | |
Online Access: | https://doi.org/10.14814/phy2.15664 |
Similar Items
-
The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels
by: Benjamin Hackl, et al.
Published: (2022-05-01) -
Pharmacological Profile of the Bradycardic Agent Ivabradine on Human Cardiac Ion Channels
by: Nicholas Haechl, et al.
Published: (2019-06-01) -
Cardiovascular phenotype of the Dmdmdx rat – a suitable animal model for Duchenne muscular dystrophy
by: Petra Lujza Szabó, et al.
Published: (2021-02-01) -
ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE IVABRADINE AND HEART RATE REDUCTION IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01) -
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01)